What Have We Learned About Bipolar Disorder From STEP-BD and Other Practical Trials?

Clicks: 5
ID: 270247
2009
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #264 of 273 articles by views in the journal of clinical psychiatry

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 273 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Article AbstractCertain developments are informing the treatment of patients with bipolar disorder. Results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study and other pragmatic clinical trials are providing practical information on relapse/recurrence, comorbidities, and pharmacologic and psychosocial treatment. Also, the Bipolar Trials Network (BTN) has been established to provide an infrastructure for National Institutes of Health (NIH) and trials with high public health significance. More research is needed to explore fundamental questions about bipolar disorder and its treatment.See the entire activity.†‹
Reference Key
nierenberg2009thewhat Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Andrew A. Nierenberg;
Journal the journal of clinical psychiatry
Year 2009
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.